Effects of Early Use of Nitazoxanide in Patients With COVID-19

NCT04552483 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

392

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Coronavirus

Interventions

DRUG: Nitazoxanide
DRUG: Placebo

Sponsor

Universidade Federal do Rio de Janeiro

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]